Acrospire Investment Management’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Acrospire Investment Management’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,740	Closed	-$27K	–	2843
2017 Q1	$27K	Sell	11,740 -20,279	-63%	-$53.3K	0.02%	1441
2016 Q4	$94K	Buy	32,019 +9,020	+39%	+$30.9K	0.04%	974
2016 Q3	$86K	Buy	22,999 +20,999	+1,050%	+$76.6K	0.06%	674
2016 Q2	$9K	Buy	+2,000	New	+$4.46K	0.01%	1785

Other funds holding BSPM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acrospire Investment Management's BSPM Position: Q2 2017 in Review

Acrospire Investment Management sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q2 2017, closing a stake of 11,740 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in BSPM in Q2 2016 and held it in 4 quarters. The position peaked at $94K in Q4 2016. 5 funds tracked by Wall St. Rank hold BSPM as of Q2 2017.

Acrospire Investment Management reported no remaining Biostar Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Acrospire Investment Management sold 11,740 Biostar Pharmaceuticals, Inc. shares in Q2 2017, an estimated $27K.
Acrospire Investment Management first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2016 and held it in 4 quarters.
Acrospire Investment Management's Biostar Pharmaceuticals, Inc. position peaked at $94K in Q4 2016.
5 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.